Fortrea introduced an AI-powered suite of clinical trial services built around its FIT platform, aimed at improving trial efficiency and reducing operational risk. The company said FIT is designed to support sponsors and investigator sites with faster, more confident execution and lower risk across trial workflows. Fortrea also highlighted components that can be delivered through SaaS, and connected the launch to prior modernization work on its risk-based monitoring platform Xcellerate. Executives framed the system as incorporating responsible and ethical AI to improve decisions derived from trial data. For biotech sponsors, the launch positions Fortrea as a CRO offering a more integrated AI layer for protocol execution, monitoring, and data-driven site and risk management decisions.